These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 27206720)

  • 1. Applying the HIV-associated neurocognitive disorder diagnostic criteria to HIV-infected youth.
    Hoare J; Phillips N; Joska JA; Paul R; Donald KA; Stein DJ; Thomas KG
    Neurology; 2016 Jul; 87(1):86-93. PubMed ID: 27206720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for HIV-associated neurocognitive disorders in perinatally infected adolescents: youth-International HIV Dementia Scale validation.
    Phillips NJ; Thomas KGF; Myer L; Sacktor N; Zar HJ; Stein DJ; Hoare J
    AIDS; 2019 Apr; 33(5):815-824. PubMed ID: 30649059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the sensitivity, stability, and reliability of three diagnostic schemes for HIV-associated neurocognitive disorders.
    Tierney SM; Sheppard DP; Kordovski VM; Faytell MP; Avci G; Woods SP
    J Neurovirol; 2017 Jun; 23(3):404-421. PubMed ID: 28108972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multivariate normative comparison, a novel method for more reliably detecting cognitive impairment in HIV infection.
    Su T; Schouten J; Geurtsen GJ; Wit FW; Stolte IG; Prins M; Portegies P; Caan MW; Reiss P; Majoie CB; Schmand BA;
    AIDS; 2015 Mar; 29(5):547-57. PubMed ID: 25587908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determining optimal impairment rating methodology for a new HIV-associated neurocognitive disorder screening procedure.
    Kamminga J; Bloch M; Vincent T; Carberry A; Brew BJ; Cysique LA
    J Clin Exp Neuropsychol; 2017 Oct; 39(8):753-767. PubMed ID: 28052738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of the International HIV Dementia Scale as a Screening Tool for HIV-Associated Neurocognitive Disorders in a German-Speaking HIV Outpatient Clinic.
    Marin-Webb V; Jessen H; Kopp U; Jessen AB; Hahn K
    PLoS One; 2016; 11(12):e0168225. PubMed ID: 27992497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Screening Strategy for HIV-Associated Neurocognitive Disorders That Accurately Identifies Patients Requiring Neurological Review.
    Bloch M; Kamminga J; Jayewardene A; Bailey M; Carberry A; Vincent T; Quan D; Maruff P; Brew B; Cysique LA
    Clin Infect Dis; 2016 Sep; 63(5):687-693. PubMed ID: 27325690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low levels of neurocognitive impairment detected in screening HIV-infected men who have sex with men: The MSM Neurocog Study.
    Barber TJ; Bansi L; Pozniak A; Asboe D; Nelson M; Moyle G; Davies N; Margetts A; Ratcliffe D; Catalan J; Boffito M; Gazzard B
    Int J STD AIDS; 2017 Jun; 28(7):715-722. PubMed ID: 27510645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of age and time of disease with HIV-associated neurocognitive disorders: a Japanese nationwide multicenter study.
    Kinai E; Komatsu K; Sakamoto M; Taniguchi T; Nakao A; Igari H; Takada K; Watanabe A; Takahashi-Nakazato A; Takano M; Kikuchi Y; Oka S;
    J Neurovirol; 2017 Dec; 23(6):864-874. PubMed ID: 28971376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of the Montreal Cognitive Assessment (MoCA) and its subset in HIV-associated neurocognitive disorder (HAND) screening.
    Kim WJ; Ku NS; Lee YJ; Ahn JY; Kim SB; Ahn HW; Hong KW; Song JY; Cheong HJ; Kim WJ; Kim JM; Namkoong K; Choi JY; Kim E
    J Psychosom Res; 2016 Jan; 80():53-7. PubMed ID: 26721548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurocognitive functioning among HIV-positive adults in southern India.
    Kamat R; McCutchan A; Kumarasamy N; Marcotte TD; Umlauf A; Selvamuthu P; Meyer R; Letendre S; Heaton R; Bharti AR
    J Neurovirol; 2017 Oct; 23(5):750-755. PubMed ID: 28681344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are MMSE and HDS-R neuropsychological tests adequate for screening HIV-associated neurocognitive disorders?
    Nakazato A; Tominaga D; Tasato D; Miyagi K; Nakamura H; Haranaga S; Higa F; Tateyama M; Fujita J
    J Infect Chemother; 2014 Mar; 20(3):217-9. PubMed ID: 24462448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What's in a name? AIDS dementia complex, HIV-associated dementia, HIV-associated neurocognitive disorder or HIV encephalopathy.
    Singh D
    Afr J Psychiatry (Johannesbg); 2012 May; 15(3):172-5. PubMed ID: 22722724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A decreasing CD4/CD8 ratio over time and lower CSF-penetrating antiretroviral regimens are associated with a higher risk of neurocognitive deterioration, independently of viral replication.
    Vassallo M; Fabre R; Durant J; Lebrun-Frenay C; Joly H; Ticchioni M; DeSalvador F; Harvey-Langton A; Dunais B; Laffon M; Cottalorda J; Dellamonica P; Pradier C
    J Neurovirol; 2017 Apr; 23(2):216-225. PubMed ID: 27815816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Operationalization of the updated diagnostic algorithm for classifying HIV-related cognitive impairment and dementia.
    Foley JM; Wright MJ; Gooding AL; Ettenhofer M; Kim M; Choi M; Castellon SA; Sadek J; Heaton RK; van Gorp WG; Marcotte TD; Hinkin CH
    Int Psychogeriatr; 2011 Jun; 23(5):835-43. PubMed ID: 21092351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Problems screening for HAND among the educationally disadvantaged.
    Musso MW; Cosgrove SJ; Peltier MR; McGee BL; Jones GN
    Appl Neuropsychol Adult; 2018; 25(2):120-125. PubMed ID: 27841663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening HIV-associated neurocognitive disorders (HAND) among HIV positive patients attending antiretroviral therapy in South Wollo, Ethiopia.
    Tsegaw M; Andargie G; Alem G; Tareke M
    J Psychiatr Res; 2017 Feb; 85():37-41. PubMed ID: 27821271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurocognitive function profile in HIV-infected school-age children.
    Koekkoek S; de Sonneville LM; Wolfs TF; Licht R; Geelen SP
    Eur J Paediatr Neurol; 2008 Jul; 12(4):290-7. PubMed ID: 17950012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. White matter micro-structural changes in ART-naive and ART-treated children and adolescents infected with HIV in South Africa.
    Hoare J; Fouche JP; Phillips N; Joska JA; Paul R; Donald KA; Thomas KG; Stein DJ
    AIDS; 2015 Sep; 29(14):1793-801. PubMed ID: 26372385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The HIV Dementia Scale: predictive power in mild dementia and HAART.
    Bottiggi KA; Chang JJ; Schmitt FA; Avison MJ; Mootoor Y; Nath A; Berger JR
    J Neurol Sci; 2007 Sep; 260(1-2):11-5. PubMed ID: 17482212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.